Integra Lifesciences Holdings (IART) Inventory Average (2010 - 2026)

Integra Lifesciences Holdings has disclosed Inventory Average across 17 years of filings, most recently posting $493.5 million for Q2 2026.

• In Q2 2026, Inventory Average rose 8.4% year-over-year to $493.5 million; the TTM figure through Jun 2026 stood at $493.5 million (up 8.4% YoY), while the FY2025 annual figure was $460.9 million, up 12.6% from the prior year.
• Inventory Average came in at $493.5 million for Q2 2026 at Integra Lifesciences Holdings, roughly flat from $493.9 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $493.9 million in Q1 2026 to a low of $315.6 million in Q3 2022.
• Average Inventory Average over 5 years is $401.6 million, with a median of $404.6 million recorded in 2024.
• Year-over-year, Inventory Average fell 3.0% in 2022 and advanced 19.17% in 2024.
• Over 5 years, Inventory Average stood at $317.8 million in 2022, then advanced by 18.91% to $377.9 million in 2023, then climbed by 14.57% to $433.0 million in 2024, then rose by 13.37% to $490.9 million in 2025, then rose by 0.53% to $493.5 million in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $493.5 million in Q2 2026, $493.9 million in Q1 2026, and $490.9 million in Q4 2025.